KENNETH BATE Insider Trading $VNDA Vanda Pharmaceuticals Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for KENNETH BATE.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of KENNETH BATE. KENNETH BATE is EVP; Chief Financial Officer in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and ExecVP; Head of Commercial Ops in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Vanda Pharmaceuticals Inc. ($VNDA) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and Director in Epizyme, Inc. ($EPZM).

KENNETH BATE in Vanda Pharmaceuticals Inc.

Trading Symbol: VNDA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH BATE: Director
Holdings: 5,000 shares
Current Value: $68,250
Latest Transaction: Jun 19 2017
$VNDA Market Capitalization: $628.43M
$VNDA Previous Close: $13.65

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of KENNETH BATE in Vanda Pharmaceuticals Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AVEO, BMRN, CATB, EPZM, GNCA, SNTA, MLNM, VNDA

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 19 2017	VNDA	Vanda Pharmaceutic ...	BATE KENNETH	Director	Option Exercise	A	13.75	10,000	137,500	10,000
Jun 19 2017	VNDA	Vanda Pharmaceutic ...	BATE KENNETH	Director	Grant	A	0.00	5,000	0	5,000	0 to 5 K
Dec 21 2015	VNDA	Vanda Pharmaceutic ...	BATE KENNETH	Director	Option Exercise	A	9.38	35,000	328,300	35,000

Page: 1